SLC5A2 and liver dysplastic nodule: Recently, numerous studies reported the reno-protective effects of SGLT2-is, a new hypoglycemic drug, such as dapagliflozin, in treating DN and its cardiovascular complications (Kovesdy et al., 2022; Liu et al., 2022).